Swiss pharmaceutical giant Novartis, a current and former subsidiary, has agreed to pay a total of $346.7m to reach settlements with the US Department of Justice (DOJ) and Securities and Exchange Commission (SEC) following investigations into bribery schemes. The DOJ alleges Greek subsidiary Novartis Hellas offered “inappropriate economic benefits” to the country’s healthcare professionals between […]

Read More